Clinical Trials Browser

Multiple Myeloma × HDAC-42 × Clear all

NCT02569320 2021-06-15

HDAC Inhibitor AR-42 and Pomalidomide in Treating Patients With Relapsed Multiple Myeloma

Phase 1 Completed

Multiple Myeloma